安捷凯在线客服
- 客服:
- 电话: 13061953619
- 微信:
神经退行性疾病靶向化合物 1 是一种钙蛋白酶抑制剂(提取自专利 WO2010128102A1,化合物 63)。
Neurodegenerative Disorder-Targeting Compound 1 is a carboxamide compound, used in the research of neurodegenerative disorders.
Neurodegenerative Disorder-Targeting Compound 1 can be used in the research of neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease[1].
[1]. MACK, Helmut., et al. CARBOXAMIDE COMPOUNDS AND THEIR USE AS CALPAIN INHIBITORS. WO 2010128102 A1.
动态评分
0.0